Jump to content
  • Sign Up


This topic is now archived and is closed to further replies.

Scott Adams

Biolinerx Announces Regulatory Submission For Phase 1/2 Trial For Novel ... - Pr Newswire (Press Release)

Recommended Posts

BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel ...

PR Newswire (press release)

JERUSALEM, Sept. 24, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it has filed the necessary regulatory submissions to commence a Phase 1/2 trial for BL-7010 - for ...

and more »

View the full article

Share this post

Link to post
Share on other sites

  • Create New...